| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/10/2009 | US20090227530 Sodium channel blockers |
| 09/10/2009 | US20090227523 Use of compatible solutes as substances having free radical scavenging properties |
| 09/10/2009 | US20090227507 Angiotensin (1-7) Dosage Forms and Uses Thereof |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090226930 Beta cell antigen |
| 09/10/2009 | US20090226528 Encapsulated nanoparticles for nucleic acid delivery |
| 09/10/2009 | US20090226512 Methods and Compositions for Oral Delivery of FTS |
| 09/10/2009 | US20090226485 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 09/10/2009 | US20090226476 Human Glycoform |
| 09/10/2009 | US20090226472 Interleukin-4 receptors |
| 09/10/2009 | US20090226457 antibody that is immunoreactive with a polypeptide used in treating autoimmune and immunological diseases |
| 09/10/2009 | US20090226445 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/10/2009 | US20090226434 Afucosylated antibodies against CCR5 and their use for the treatment of inflammatory conditions |
| 09/10/2009 | US20090226433 Compositions and methods for the therapy and diagnosis of influenza |
| 09/10/2009 | US20090226431 Treatment of Cancer and Other Diseases |
| 09/10/2009 | US20090226430 Recombinant anti-cd4 antibodies for human therapy |
| 09/10/2009 | US20090226428 Anti-inflammatory dab |
| 09/09/2009 | EP2098248A1 Combination of anticholinergics, glucocorticoids and beta2-agonists for the treatment of inflammatory diseases |
| 09/09/2009 | EP2098246A1 Method for promoting immune response comprising inhibiting cd22 function in b cells |
| 09/09/2009 | EP2098245A1 Use of cholinesterase for manufacturing an anti-tachykinins medicament |
| 09/09/2009 | EP2097534A2 Human antibodies that bind cd70 and uses thereof |
| 09/09/2009 | EP2097529A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 09/09/2009 | EP2097455A2 Humanized anti-factor d antibodies |
| 09/09/2009 | EP2097384A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 09/09/2009 | EP2097371A2 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 09/09/2009 | EP2097098A1 Expression of transgenic t cell receptors in lak-t cells |
| 09/09/2009 | EP2097087A2 Suppressive macrophages, c-reactive protein and the treatment of systemic lupus erythematosus and immune thrombocytopenic purpura |
| 09/09/2009 | EP1856045B1 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 09/09/2009 | EP1519724B1 Fredericamycin derivatives as medicaments for treating tumours |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | EP1389219B1 Dimerized t-cell receptor fragment, its compositions and use |
| 09/09/2009 | EP1379270B1 Use of anti-cd3 monoclonal antibodies and il-5 for treating autoimmune diseases |
| 09/09/2009 | EP0817847B2 Il-17 receptor |
| 09/09/2009 | EP0771147B1 Compositions and methods for enhanced tumor cell immunity in vivo |
| 09/09/2009 | CN101525573A White koji mature vinegar and preparation method thereof |
| 09/09/2009 | CN101525385A Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases |
| 09/09/2009 | CN101525384A A bispecific antibody and the making method and the application thereof |
| 09/09/2009 | CN101524527A TAT-HOXB4H fusion protein used as hematopoiesis irritant and the pharmaceutical composition thereof |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524492A Traditional Chinese peroral preparation with immunity-strengthening function and preparation method thereof |
| 09/09/2009 | CN101524393A Preparation method of gypenoside |
| 09/09/2009 | CN101524385A Preparation process for ginseng extract |
| 09/09/2009 | CN101524377A Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
| 09/09/2009 | CN101524376A Extrusion wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524375A Wet-process wall breaking method of lucidum spore powder |
| 09/09/2009 | CN101524374A Auricularia Polytricha(Mont)Sacl fermentation product, oral preparation containing same, preparation method and application |
| 09/09/2009 | CN101524353A Oral anti-allergy compound pharmaceutical composition |
| 09/09/2009 | CN101524190A Disease preventing and curing medicinal mouth-muffle and medicinal composite |
| 09/09/2009 | CN100537773C Modified vaccinia ankara virus variant |
| 09/09/2009 | CN100537585C Glycolipids derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100536919C Interferon antagon and usage of Flt3L antagon |
| 09/09/2009 | CN100536910C Thymosin alpha 1 peptide/polymer conjugates |
| 09/09/2009 | CN100536863C Soybean saponin-containing material and process for producing the same |
| 09/09/2009 | CN100536845C Loratadine paster of penetrating skin |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/08/2009 | US7585947 IL-7 drug substance, composition, preparation and uses |
| 09/08/2009 | US7585946 Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585522 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 09/08/2009 | US7585520 Compositions containing both sedative and non-sedative antihistamines and sleep aids |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
| 09/08/2009 | CA2555911C Adjuvant compositions containing 3-o deacylated monophosphoryl lipid a |
| 09/08/2009 | CA2468833C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 09/08/2009 | CA2442210C Aryl oxime-piperazines useful as ccr5 antagonists |
| 09/08/2009 | CA2352777C Preparations containing virus-like particles as immunopotentiators administered through the mucosa |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 09/08/2009 | CA2290745C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 09/08/2009 | CA2252604C Methods of treating type i hypersensitivity using monophosphoryl lipid a |
| 09/08/2009 | CA2218701C Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof |
| 09/03/2009 | WO2009108118A1 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009107387A1 2-oxochromene derivative |
| 09/03/2009 | WO2009107380A1 Anti-allergic agent |
| 09/03/2009 | WO2009107223A1 Method of producing ceramide |
| 09/03/2009 | WO2009106975A2 Activation of innate and adaptive immune responses by a ginseng extract |
| 09/03/2009 | WO2009106844A1 Inhibitors of p38 map kinase |
| 09/03/2009 | WO2009106773A2 Transgenic non-human mammal for the constant region of the g-class human immunoglobulin heavy chain and applications thereof |
| 09/03/2009 | WO2009106752A2 Derivatives of 2-heteroaroyl-imidazol[1,2-a]pyridine, preparation thereof and therapeutic application thereof |
| 09/03/2009 | WO2009106708A2 Azetidine derivatives, their preparation and their application in therapy |
| 09/03/2009 | WO2009106579A1 Methods for prognosing the status of tumor patients |
| 09/03/2009 | WO2009106539A1 Heterocyclic compounds as inhibitors of cxcr2 |
| 09/03/2009 | WO2009106368A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 09/03/2009 | WO2009065561A3 System for delivery into a xcr1 positive cell and uses thereof |
| 09/03/2009 | WO2009049742A3 Use of melanotrophin-potentiating factor as a therapeutic agent |
| 09/03/2009 | WO2009046829A3 Casoxin d as a therapeutic agent |
| 09/03/2009 | WO2009043480A3 Use of leptin (22-56 ) as a therapeutic agent |
| 09/03/2009 | WO2009043469A3 Use of pneumadin as a therapeutic agent |
| 09/03/2009 | WO2009040018A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009040017A3 Use of a peptide as a therapeutic agent |
| 09/03/2009 | WO2009039993A3 Use of melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039992A3 Use of band 3 protein (824-829) and/or melanocyte-stimulating hormone release-inhibiting factor as a therapeutic agent in the treatment of pseudomonas aeruginosa infection |
| 09/03/2009 | WO2009039988A3 Use of a fibrinogen receptor antagonist and/or follicular gonadotropin releasing peptide as a therapeutic agent in the treatment of streptococcus pneumonia infection |
| 09/03/2009 | WO2009033805A3 Use of somatostatin-14 as a therapeutic agent |
| 09/03/2009 | WO2009033802A3 Antide as a therapeutic agent |
| 09/03/2009 | WO2009033801A3 Syndyphalin alone or in combination with antide as a therapeutic agent |
| 09/03/2009 | WO2009033755A3 Use of l-carnosine as a therapeutic agent |